These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7782049)

  • 1. Enhanced nocturnal melatonin secretion in women with functional secondary amenorrhea: relationship to opioid system and endogenous estrogen levels.
    Okatani Y; Sagara Y
    Horm Res; 1995; 43(5):194-9. PubMed ID: 7782049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of nocturnal melatonin secretion in women with functional secondary amenorrhoea: relation to endogenous oestrogen concentration.
    Okatani Y; Sagara Y
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):763-70. PubMed ID: 7889612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked augmentation of nocturnal melatonin secretion in amenorrheic athletes, but not in cycling athletes: unaltered by opioidergic or dopaminergic blockade.
    Laughlin GA; Loucks AB; Yen SS
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1321-6. PubMed ID: 1955514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations.
    Okatani Y; Morioka N; Wakatsuki A
    J Pineal Res; 2000 Mar; 28(2):111-8. PubMed ID: 10709973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
    Shoupe D; Montz FJ; Lobo RA
    J Clin Endocrinol Metab; 1985 Jan; 60(1):178-83. PubMed ID: 2981084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea.
    Berga SL; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Jan; 66(1):242-4. PubMed ID: 3335608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist.
    Khoury SA; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1987 Apr; 64(4):755-62. PubMed ID: 2880864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone.
    Melis GB; Paoletti AM; Gambacciani M; Mais V; Fioretti P
    Neuroendocrinology; 1984 Jul; 39(1):60-3. PubMed ID: 6087184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG; Mortola JF; Yen SS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circadian rhythm of plasma melatonin during the normal menstrual cycle and in amenorrheic women.
    Brzezinski A; Lynch HJ; Seibel MM; Deng MH; Nader TM; Wurtman RJ
    J Clin Endocrinol Metab; 1988 May; 66(5):891-5. PubMed ID: 3129448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endogenous opiates in athletic amenorrhea.
    Samuels MH; Sanborn CF; Hofeldt F; Robbins R
    Fertil Steril; 1991 Mar; 55(3):507-12. PubMed ID: 1900478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of prolactin secretion by melatonin is not mediated by opioids.
    Okatani Y; Okada M; Sagara Y
    Horm Res; 1994; 41(1):38-42. PubMed ID: 8013942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroids modulate prolactin response to naloxone in postmenopausal women.
    Melis GB; Gambacciani M; Paoletti AM; Mais V; Cagnacci A; Petacchi FD; Fioretti P
    Neuroendocrinology; 1985 Aug; 41(2):138-41. PubMed ID: 2995857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of natural estrogens in young females with secondary amenorrhea.
    Spona J; Schneider WH
    Acta Obstet Gynecol Scand Suppl; 1977; 65():33-8. PubMed ID: 199037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated nocturnal melatonin is a consequence of gonadotropin-releasing hormone deficiency in women with hypothalamic amenorrhea.
    Kadva A; Djahanbakhch O; Monson J; Di WL; Silman R
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3653-62. PubMed ID: 9768680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian pattern of plasma melatonin concentrations during four phases of the human menstrual cycle.
    Berga SL; Yen SS
    Neuroendocrinology; 1990 May; 51(5):606-12. PubMed ID: 2112733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical study on the relationship between the pineal gland and the opioid system.
    Lissoni P; Esposti D; Esposti G; Mauri R; Resentini M; Morabito F; Fumagalli P; Santagostino A; Delitala G; Fraschini F
    J Neural Transm; 1986; 65(1):63-73. PubMed ID: 2937880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal melatonin secretion in male patients with hypogonadism.
    Luboshitzky R; Wagner O; Lavi S; Herer P; Lavie P
    J Mol Neurosci; 1996; 7(2):91-8. PubMed ID: 8873893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.